ReVac: a reverse vaccinology computational pipeline for prioritization of prokaryotic protein vaccine candidates.
Adonis D'MelloChristian P AhearnTimothy F MurphyHervé TettelinPublished in: BMC genomics (2019)
ReVac's use of a scoring scheme ranks PVCs for subsequent experimental testing. It employs a redundancy-based approach in its predictions of features using several prediction tools. The protein's features are collated, and each protein is ranked based on the scoring scheme. Multi-genome analyses performed in ReVac allow for a comprehensive overview of PVCs from a pan-genome perspective, as an essential pre-requisite for any bacterial subunit vaccine design. ReVac prioritized PVCs of two human respiratory pathogens, identifying both novel and previously validated PVCs.